1.Current research of retinal ischemia model in rodent
Chinese Journal of Experimental Ophthalmology 2013;(5):513-516
Retinal ischemia is a common cause of blindness and visual impairment.Some eye diseases,such as glaucoma,retinal artery occlusion and diabetic retinopathy,are associated with retinal ischemia.It is very important to build an ideal animal model which can imitate human retinal ischemia disease for investigating the pathological mechanism and treatment of retinal ischemia.Rodent is a popular choice for retinal ischemia model due to its availability and the similarity to human retinal blood supply.To provide a supportive evidence of retinal ischemia research,some literature concerning rodent models is reviewed and various methods to build the model are summarized,such as elevated intraocular pressure,optic nerve ligation,ligation of vessels,photo-chemistry,endothelin-1 injection and middle cerebral artery occlusion intraluminal suture,etc.Here,the specific protocols,the pathological changes and molecular mechanism of each model are reviewed.
2.Research on distribution of patents' holders for Chinese herbal compounds in treating cardiovascular and cerebrovascular based on cluster analysis.
China Journal of Chinese Materia Medica 2015;40(18):3682-3686
To discuss the distribution of patents' holders for Chinese herbal compounds in treating cardiovascular and cerebrovascular, the patents' holders for Chinese herbal compounds in treating cardiovascular and cerebrovascular were cluster analyzed by means of simple statistics and cluster analysis. Clustering variables were composed of patent applications, patent maintained number, related papers' quantity, etc. Chinese herbal compound patents' holders were divided into four categories according to their different scientific research and patent strength. It is the magic weapon for Chinese herbal compound patents' holders that have scientific research patents' transforming and make coordination of patent protection and scientific innovation.
Biometry
;
Cardiovascular Diseases
;
drug therapy
;
Cerebrovascular Disorders
;
drug therapy
;
Cluster Analysis
;
Drugs, Chinese Herbal
;
economics
;
therapeutic use
;
Herbal Medicine
;
economics
;
legislation & jurisprudence
;
manpower
;
statistics & numerical data
;
Humans
;
Medicine, Chinese Traditional
;
economics
;
Patents as Topic
3.Effect of dexmedetomidine on noise-induced hearing loss in guinea pigs
Ying XIAO ; Jian WEN ; Guixia JING ; Min XU ; Yanxia BAI
Chinese Journal of Anesthesiology 2013;33(11):1296-1299
Objective To evaluate the effect of dexmedetomidine on noise-induced hearing loss in guinea pigs.Methods Twenty-four adult male guinea pigs,aged 3 months,weighing 400-500 g,were randomly divided into 3 groups (n =8 each) using a random number table:dexmedetomdine group (group D),noise-induced hearing loss group (group N) and dexmedetomidine + noise-induced hearing loss group (group DN).A loading dose of dexmedetomidine 5 μg/kg was infused over 5 min,followed by 135 min of infusion at a rate of 10 μg· kg-1 · h-1.The equal volume of normal saline was infused in group N.Groups N and DN were exposed to noise of 4 kHz center frequency and 118-122 dB SPL for 120 min starting from 20 min of administration.Mean arterial pressure (MAP) and cochlear blood flow (COBF) were recorded before administration and every 5 min during drug administration.The changing rate of COBF was calculated.Arterial blood samples were collected for determination of plasma concentration of noradrenaline (NE) by high performance liquid chromatography at 20 and 140 min of administration.Auditory brainstem response (ABR) threshold was recorded before administration and at 1 and 72 h and 10 days after the end of administration.Results Compared with group N,MAP was significantly decreased,the changing rate of COBF was increased at 5-10 min and 30-140 min of administration,ABR threshold was decreased at 1 and 72 h and 10 days after the end of administration,and the plasma concentration of NE was decreased at 140 min of administration in D + N group (P < 0.05).Conclusion Dexmedetomidine can attenuate noise-induced hearing loss in guinea pigs possibly through inhibiting activation of sympathetic nerves and increasing COBF.
4.Influence of psychological intervention on aged patients with femoral neck fractures when cured by artificial hip replacement
Yang XU ; Yonqiu XIAO ; Hua QI ; Ying LI
Chinese Journal of Practical Nursing 2009;25(27):51-52
Objective To know the effect of psychological nursing for aged patients with femoral neck fractures when cured by artificila hip replacement. Methods Divided 158 aged patients with femoral neck fractures into the intervention group (84 cases) and control group (68 cases) randomly. Routine nursing cares were used in the control group, while the psychological nursing intervention were used in the intervention group in addition. Compared the degree of postoperative pains and preoperative anxiety between the two groups, and then evaluated the function of limbs. Results The degree of postoperative pains and preoperative anxiety in the interventioni group was better than that of in control group respectively, the condition of limb function was better in the intervention group than in the control group. Conclusions Psychological intervention can promote rehabilitation for aged patients with femoral neck fractures when cured by artificila hip replacement, which can guarantee the satisfactory prognosis.
5.Effect of puerarin on action potential and inward rectifier potassium current in rat myocardium.
Chinese Journal of Applied Physiology 2010;26(2):246-248
Action Potentials
;
drug effects
;
physiology
;
Animals
;
Anti-Arrhythmia Agents
;
pharmacology
;
Female
;
Heart Ventricles
;
metabolism
;
Isoflavones
;
pharmacology
;
Male
;
Microelectrodes
;
Myocardium
;
metabolism
;
Patch-Clamp Techniques
;
Potassium Channels, Inwardly Rectifying
;
metabolism
;
physiology
;
Rats
;
Ventricular Function
;
physiology
8.Clinical Observation of Recombinant Human Endostatin Combined with Irinotecan and Lobaplatin in the Treatment of Advanced Recurrent Small Cell Lung Cancer
Yin XIAO ; Moran LIU ; Zhongling XU ; Guang ZHEN ; Ying WANG
China Pharmacy 2017;28(20):2843-2846
OBJECTIVE:To observe the clinical efficacy and safety of recombinant human endostatin (rh-endostatin) combined with Lobaplatin for injection and irinotecan injection in the treatment of advanced recurrent small cell lung cancer (SCLC). METHODS:A total of 88 patients with advanced recurrent SCLC in our hospital were divided into control group (41 cases) and observation group (47 cases) according to random number table. Control group was given Irinotecan injection+Lobaplatin for injection. Observation group was additionally given Recombinart human endostatin injection 15 mg added into 0.9%Sodium chloride injection 250 mL,ivgtt,qd,for consecutive 14 d,every 14 d. A treatment course lasted for 28 d,and both groups were treated for 2 courses. The clinical efficacy,the levels of serum carcinoembryonic antigen(CEA),the scores physical state (ECOG) and quality of life (QOL) before,after treatment were observed in the two groups,and the survival and adverse reactions of the two groups were compared. RESULTS:The total response rate of observation group was 59.6%,which was higher than 43.9% of control group,but there was no statistical significance (P>0.05). Before treatment, there was no significant difference in serum CEA levels,ECOG scores or QOL scores,between 2 groups(P>0.05);after treatment,the serum CEA levels of the two groups were significantly decreased,and the observation group was significantly lower than the control group,with statistically significant (P<0.05). In observation group,ECOG scores decreased while QOL scores increased significantly,and significantly better than the control group,with statistical significance(P<0.05). The overall survival(OS)of observation group was 16.8 months,which was significantly higher than 11.5 months of control group,with statistical significance (P<0.05). The incidence of leucopenia in observation group was significantly higher than control group;the incidence of leucopenia and abnormal liver function were significantly lower than control group,with statistical significance(P<0.05). CONCLUSIONS:Rh-endostatin injection combined with lobaplatin and irinotecan can improve serum CEA levels and the quality of living aswell as prolong the survival time.
9.Comparison of cold blood and cold crystalloid cardioplegia on myocardial protection effects in valve replacement surgery
Yingqi XU ; Sanqing JIN ; Ying XIAO ; Xi ZHANG ; Jianping YAO
Journal of Chinese Physician 2001;0(02):-
Objective To compare the myocardial protection effects of cold blood cardioplegia and cold crystalloid cardioplegia in patients undergoing valve replacement surgery.Methods One hundred adult patients with cardiac function Ⅱ~Ⅲ class undergoing primary elective valve replacement surgery due to rheumatic heart disease were retrospectively analyzed.For patients with cardiac arrest,cold blood cardioplegia was applied to 50 cases(Group B),and cold crystalloid cardioplegia to the others(group C).The process of heart resuscitation,the postoperative need of dopamine,the blood pressure and heart rate,the postoperative level of serum myocardial enzyme,the intensive care unit(ICU) stay after operation were collected and statistically analyzed.All the cardioplegic solution was perfused in a similar manner and topical cooling was employed simultaneously.Results There were less cases in group B than in group C who needed isoprenaline for cardiac resuscitation after clamp removal(P0.05).Conclusion The cold blood cardioplegia and cold crystalloid cardioplegia have similar myocardial protection effects on rheumatic heart disease patients with cardiac function Ⅱ~Ⅲ class undergoing valve replacement surgery.
10.A meta-analysis of mood stabilizers for Alzheimer's disease.
Haibing, XIAO ; Ying, SU ; Xu, CAO ; Shenggang, SUN ; Zhihou, LIANG
Journal of Huazhong University of Science and Technology (Medical Sciences) 2010;30(5):652-8
The objective of this study was to assess the clinical evidence for or against mood stabilizers as a treatment for Alzheimer's disease (AD). We searched 5 databases from their inception to January 2010. Five randomized clinical trials of mood stabilizers to treat human patients suffering from AD were included. These trials assessed the effectiveness of mood stabilizers as an adjunct treatment to conventional anti-dementia drugs on behavioral and psychological symptoms, especially on agitation. Methodological quality was assessed using the Jadad score. The results suggested a significant effect in favor of placebo on the Mini-Mental Status Examination [n=270, weight mean difference (WMD), -0.89; 95% confidence intervals (CIs) -1.69 to -0.09, P=0.03] and on the Neuropsychiatric Inventory total (NPI total) (n=51, WMD, 3.71; 95% CIs 0.15 to 7.26, P=0.04). There were no significant differences in change scores on total Brief Psychiatric Rating Scale (BPRS total), NPI/BPRS agitation, Cohen-Mansfield Agitation Inventory total and Physical Self Maintenance Scale between mood stabilizers and placebo. Only one of these studies was free of methodological limitations (Jadad score=5). In conclusion, based on the existing evidence, mood stabilizers are ineffective or even harmful as a treatment for AD.